Cancer vaccine halves melanoma risk
A new experimental vaccine has been developed that reduces the risk of melanoma recurrence or death from the cancer by 49% over five years, representing significant progress in the treatment of this type of cancer. According to Dr. Hizkiyahu Emanuel, a former health policy advisor at the White House, this new therapy could enhance the effectiveness of cancer control strategies and change the future of treatment for skin cancer patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)